Indication
IOP
1 clinical trial
2 products
Clinical trial
Bisphosphonates for Prevention of Post-Denosumab Bone Loss in Premenopausal Women With Idiopathic OsteoporosisStatus: Completed, Estimated PCD: 2023-06-09
Product
AlendronateProduct
Zoledronic Acid